Billing for patient portal messages is associated with a modest decrease in patient-initiated message volume, data suggest.
Researchers found evidence to suggest that drinking coffee or tea daily may reduce a person’s risk of developing head and neck cancer.
The FDA has approved subcutaneous nivolumab and hyaluronidase-nvhy (Opdivo Qvantig) to treat a range of solid tumor malignancies.
Norovirus cases are on the rise in the United States this winter, according to data from the US Centers for Disease Control and Prevention.
This page includes links to articles highlighting the top breast cancer research published on Cancer Therapy Advisor in 2024.
(HealthDay News) — Cannabidiol (CBD) appears safe and may reduce anxiety in patients with advanced breast cancer, according to a study published in JAMA Network Open.
Many patients with multiple myeloma experience persistent pain and use opioids to manage that pain even after they achieve remission, a survey suggests.
This page includes links to articles highlighting the top hematologic cancer research published on Cancer Therapy Advisor in ...
Source: Getty Images Data presented at SABCS 2024 suggest that certain patients can safely skip sentinel lymph node biopsy, ...
Bicistronic CAR T-cell therapy can produce durable complete responses in pediatric patients with relapsed or refractory B-ALL, data suggest.
The FDA has approved Tevimbra (tislelizumab) for use in combination with chemotherapy to treat unresectable or metastatic, HER2-, PD-L1+ gastric or GEJ adenocarcinoma.
(HealthDay News) — The mean body mass index (BMI) and prevalence of obesity declined in the United States in 2023, according to research published in JAMA Health Forum.